Возраст домена | 14 лет |
Дата окончания | Истек срок регистрации |
PR | 1 |
ИКС | |
Страниц в Google | 40700 |
Страниц в Яндексе | 79 |
Dmoz | Нет |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 304968 |
Alexa Country | ![]() |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
Dry Eye Summit - Dry Eye Drug Development Life Cycle
Dry Eye
Dry Eye Summit 2010 Video Content
UTF-8
11.05 КБ
224
1 643 симв.
1 370 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
![]() ![]() |
11 | 8 |
0 | 10 | ![]() | |
![]() ![]() |
9 | 7 |
0 | 3848 | ![]() | |
![]() ![]() |
9 | 6 |
0 | 440032 | ![]() | |
![]() ![]() |
8 | 3 |
0 | 1866572 | ![]() |
|
![]() ![]() |
7 | 5 |
10 | 16258546 | ![]() |
|
![]() ![]() |
7 | 5 |
0 | 16089 | ![]() | |
![]() ![]() |
7 | 5 |
0 | 14774 | ![]() | |
![]() ![]() |
6 | 8 |
0 | 113 | ![]() | |
![]() ![]() |
6 | 7 |
0 | 552 | ![]() | |
![]() ![]() |
4 | 6 |
30 | 147575 | ![]() | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
![]() | Нет доступа | Нет доступа | n/a |
Ссылок в Alexa | 429 |
Данные linkpad ( 15 Марта 2013 ) | |
Количество ссылок на сайт | 168 |
Количество доменов, которые ссылаются на сайт | 85 |
Количество найденных анкоров | 118 |
Исходящие (внешние) ссылки домена | 123 |
Количество доменов, на которые ссылается сайт | 20 |
Количество исходящих анкоров | 13 |
Внешние ссылки главной страницы ( 18 ) | |
youtu.be/MWdObcDkLBk | Mark B. Abelson What is Dry Eye? |
youtu.be/bdHNLMuSHK8 | Keith Lane The Role of Blink in Dry Eye |
youtu.be/W6lSLqbY-LI | Les Kaplan, PhD Why is Dry Eye so Difficult to Study? |
youtu.be/ueYSao8XJLQ | Group Discussion How does the FDA assess the differences between Phase II and III results? |
youtu.be/25xwrw-BN8o | Group Discussion What is the FDA's position on bioequivalence studies to Restasis? |
youtu.be/Zwdickvlk1s | Group Discussion Could you market a drug that matches Restasis' efficacy endpoints, but has a better safety profile? |
youtu.be/6uwMqsswYKg | Group Discussion Is it time to move to studies that target specific Dry Eye deficiencies? |
youtu.be/b5O0Lw2iO5Q | Group Discussion Does it make sense to invest in Dry Eye? |
youtu.be/020sm--_zo4 | Group Discussion How is better understanding of biomarkers and patient segmentation affecting investment decisions? |
youtu.be/jQJoRiUAwsM | Group Discussion Is there an 'innovation gap' between early-stage and late-stage Dry Eye development? |
youtu.be/Nca1C-gWy2w | Group Discussion What is the effect of dry eye chamber patient selection on labeling language for drug indications? |
youtu.be/rVfPk5aSVwc | Group Discussion Is mean change from baseline in a sign or symptom an acceptable endpoint for primary approval? |
youtu.be/3AN4VkgHWVU | Group Discussion What does the FDA look for from Dry Eye Phase II study results? |
youtu.be/H4CCiFBWvjE | Group Discussion Deal Structure Activity Relationships |
youtu.be/Bwdr9Abvrco | Group Discussion How do Dry Eye chamber results correlate from mice to humans? |
youtu.be/5twGRx1kk04 | Group Discussion At which development stage do investors consider an investment in a Dry Eye product? |
youtu.be/BW65UUoyxeQ | Group Discussion How important is CMC in the clinic? |
youtu.be/JmmNBOBSIf0 | Group Discussion At what stage is IP considered when a potential deal presents itself? |
[Querying whois.publicinterestregistry.net]
[whois.publicinterestregistry.net]
Access to .ORG WHOIS information is provided to assist persons in
determining the contents of a domain name registration record in the
Public Interest Registry registry database. The data in this record is provided by
Public Interest Registry for informational purposes only, and Public Interest Registry does not
guarantee its accuracy. This service is intended only for query-based
access. You agree that you will use this data only for lawful purposes
and that, under no circumstances will you use this data to: (a) allow,
enable, or otherwise support the transmission by e-mail, telephone, or
facsimile of mass unsolicited, commercial advertising or solicitations
to entities other than the data recipient's own existing customers; or
(b) enable high volume, automated, electronic processes that send
queries or data to the systems of Registry Operator, a Registrar, or
Afilias except as reasonably necessary to register domain names or
modify existing registrations. All rights reserved. Public Interest Registry reserves
the right to modify these terms at any time. By submitting this query,
you agree to abide by this policy.
Domain ID:D157964256-LROR
Domain Name:DRYEYESUMMIT.ORG
Created On:02-Jan-2010 20:15:01 UTC
Last Updated On:03-Jan-2012 09:55:26 UTC
Expiration Date:02-Jan-2014 20:15:01 UTC
Sponsoring Registrar:GoDaddy.com, LLC (R91-LROR)
Status:CLIENT DELETE PROHIBITED
Status:CLIENT RENEW PROHIBITED
Status:CLIENT TRANSFER PROHIBITED
Status:CLIENT UPDATE PROHIBITED
Registrant ID:CR39666078
Registrant Name:Joseph Bardetti
Registrant Organization:Ora
Registrant Street1:300 Brickstone Square
Registrant Street2:
Registrant Street3:
Registrant City:Andover
Registrant State/Province:Massachusetts
Registrant Postal Code:01810
Registrant Country:US
Registrant Phone:+1.9783329455
Registrant Phone Ext.:
Registrant FAX:+1.9786890020
Registrant FAX Ext.:
Registrant Email:jbardetti@oraclinical.com
Admin ID:CR39666087
Admin Name:Joseph Bardetti
Admin Organization:Ora
Admin Street1:300 Brickstone Square
Admin Street2:
Admin Street3:
Admin City:Andover
Admin State/Province:Massachusetts
Admin Postal Code:01810
Admin Country:US
Admin Phone:+1.9783329455
Admin Phone Ext.:
Admin FAX:+1.9786890020
Admin FAX Ext.:
Admin Email:jbardetti@oraclinical.com
Tech ID:CR39666082
Tech Name:Joseph Bardetti
Tech Organization:Ora
Tech Street1:300 Brickstone Square
Tech Street2:
Tech Street3:
Tech City:Andover
Tech State/Province:Massachusetts
Tech Postal Code:01810
Tech Country:US
Tech Phone:+1.9783329455
Tech Phone Ext.:
Tech FAX:+1.9786890020
Tech FAX Ext.:
Tech Email:jbardetti@oraclinical.com
Name Server:NS.INMOTIONHOSTING.COM
Name Server:NS2.INMOTIONHOSTING.COM
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
Name Server:
DNSSEC:Unsigned
США - Ашберн - 107.20.226.53
Amazon.com
Amazon.com
HTTP/1.1 200 OK
Date: Wed, 13 Nov 2019 01:49:20 GMT
Server: Apache
Accept-Ranges: bytes
Vary: Accept-Encoding
Content-Length: 11311
Content-Type: text/html
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"